Background. Dynamic arterial elastance (Ea dyn ), the relationship between pulse pressure variation (PPV) and stroke volume variation (SVV), has been suggested as a functional assessment of arterial load. The aim of this study was to evaluate the impact of arterial load changes during acute pharmacological changes, fluid administration, and haemorrhage on Ea dyn . Methods. Eighteen anaesthetized, mechanically ventilated New Zealand rabbits were studied. Arterial load changes were induced by phenylephrine (n¼9) or nitroprusside (n¼9). Thereafter, animals received a fluid bolus (10 ml kg
circumstances such as sepsis, vasoactive therapy, or acute haemorrhage could alter the pressure-flow relationship, [5] [6] [7] [8] hence the PP/SV interaction. The ratio of the pulse pressure variation (PPV) to the stroke volume variation (SVV) during a mechanical breath has been called dynamic arterial elastance (Ea dyn ). 9 10 The Ea dyn depicts the slope of the pressure-flow relationship during a respiratory cycle, and it may be a useful parameter to predict arterial pressure response after fluid administration in preload-dependent patients. 10 11 Rather than a steady-state index, Ea dyn represents the dynamic interaction between changes in arterial pressure and SV during a respiratory cycle and has been considered a functional parameter of arterial load. 10 Given that the relationship between arterial PP and SV is determined by the interaction between the left ventricle and the arterial system, 12 the impact of changes in the arterial system could alter the relationship between PPV and SVV and consequently also Ea dyn . We therefore hypothesized that changes in arterial load would significantly alter the PPV/SVV relationship (i.e. Ea dyn ). In addition, we also aimed to determine the arterial and cardiac factors that could potentially influence this relationship, in order to understand the physiological mechanisms involved in Ea dyn changes. We tested this hypothesis in an experimental rabbit model of arterial load variations induced by vasoactive administration, fluid expansion, and acute bleeding.
Methods
Eighteen New Zealand rabbits 2.5 (0.3) kg, supplied by the Reproduction Laboratory of the University of Cadiz, were maintained at a controlled temperature (23 C) in individual cages on a 12 h-12 h light-dark cycles with free access to food and water up to the time of experimental procedures. All procedures and protocols in this investigation were reviewed and approved by the Ethical Committee for Animal Experimentation of the School of Medicine of the University of Cadiz (license 07-9604). Animal care and use procedures conformed to European Ethical Standards (2012/707/EU) and Spanish Law (RD 53/2013) for the care and use of laboratory animals for experimental research. Relevant aspects of the ARRIVE guidelines were followed.
Animal preparation and instrumentation
Animals were premedicated with an i.m. dose of xylazine hydrochloride (10 mg kg
À1
) and ketamine (40 mg kg
). A tracheostomy was performed, and animals were mechanically ventilated (Servo 900c; Siemens-Elema, Solna, Sweden) in volume-controlled mode, with a tidal volume of 8 ml kg
, PEEP of 0 kPa, inspiratoryto-expiratory ratio of 1:2, fractional inspired O 2 of 0.6, and the respiratory rate adjusted to maintain an end-tidal CO 2 between 4.6 and 6 kPa. The right internal jugular vein was catheterized for a continuous adminstration of ketamine (15-20 mg kg À1 h
) and xylazine (6 mg kg À1 h
). Neuromuscular block was maintained with a rocuronium bromide infusion (1 mg kg À1 h
). Ringer's lactate solution (6 ml kg À1 h
) was administered as a maintenance fluid therapy. A 22-gauge sterile polyethylene catheter was inserted into the femoral artery and connected to a pressure transducer (TruWave; Edwards Lifesciences LLC, Irvine, CA, USA). The transducer was zeroed against atmospheric pressure, and optimal damping of the arterial waveform was checked by flushing the line before any recording. The left femoral vein was used to administer vasoactive agents and the fluid bolus. The adequacy of anaesthesia throughout the experiment was assessed by physiological responses to a nociceptive stimulus (tail clamping).
Haemodynamic monitoring
A paediatric oesophageal Doppler probe (KDP72; Deltex Medical, UK) was introduced into the oesophagus until the optimal outline and maximal peak velocity (PV) of the aortic blood waveform was obtained. Given that the aortic diameter was estimated by the Doppler system (CardioQ Combi, Deltex Medical, Chichester, UK) using a nomogram for human adults, we calculated cardiac output (CO) using the minute distance of aortic blood flow (MD) as follows: CO ¼ 1.158Â(MDÂanimal height 2 Â10 À7 ) 0.785 . 13 The MD represents the distance travelled by a column of blood in 1 min and is calculated by the Doppler system as the product of heart rate (HR) and the velocity-time integral of the aortic flow waveform (i.e. stroke distance). The arterial pressure signal was transferred from the multiparametric monitor (S/5; Datex-Ohmeda, Helsinki, Finland) to the Doppler system and automatically synchronized with the aortic blood flow waveform.
Arterial load assessment
A three-element Windkessel model was used for characterizing the arterial system, 14 15 and characteristic impedance (Z c ).
The Z c represents the arterial input impedance in the absence of arterial wave reflections. 16 Assuming that reflections are minimal at the beginning of the systole, Z c was calculated as the slope of the early ejection pressure-flow relationship, using the ratio between the maximal first derivative of pressure (dP max /dt) and flow (dQ max /dt) during 10 consecutive cardiac cycles. 17 18 An example of this calculation is shown in the Supplementary material. The effective arterial elastance was computed as Ea¼end-systolic pressure/SV, and used as a combined parameter that represents both resistive and pulsatile components of arterial load. 12 The dicrotic notch pressure was used as an estimate of end-systolic pressure.
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Pulse pressure variation, stroke volume variation, and dynamic arterial elastance Editor's key points
• Dynamic arterial elastance (Ea dyn ) describes the relationship between pulse pressure variation (PPV) and stroke volume variation (SVV) and may be useful as a functional measure of arterial load.
• The impact of arterial load changes on Ea dyn was measured in a rabbit model.
• Acute changes in arterial load affected Ea dyn and the impact of arterial and cardiac factors was different for PPV and SVV.
• Ea dyn may be considered as a ventriculo-arterial coupling index in this animal model. SV max were determined by integrating the systolic component of aortic blood flow waveform, whereas PPV was calculated from the femoral arterial pressure waveform (Supplementary material). The PPV and SVV were determined simultaneously and averaged during 1 min using a customized routine in Excel (Microsoft Corporation, Redmond, WA, USA; Supplementary material Fig. S3 ). The Ea dyn was calculated as PPV/SVV. 19 
Experimental protocol
After allowing time for haemodynamic stabilization (MAP and HR variation <5% throughout at least a 5 min period), a baseline measurement was obtained. Animals were then assigned randomly to receive a continuous infusion of phenylephrine (phenylephrine hydrochloride; Sigma-Aldrich, Munich, Germany; dosage: 20-100 lg kg À1 min À1 ) in the phenylephrine group (n¼9) or sodium nitroprusside (Nitroprussiat Fides; Rottapharm Madaus, Barcelona, Spain; dosage: 100-200 lg kg À1 min À1 ) in the nitroprusside group (n¼9). The rate of infusions was adjusted to modify MAP by $50% of the baseline value. Once the desired MAP value was reached, the rate of vasoactive administration was kept unchanged, and a new measurement was performed (arterial load change). Afterwards, a fluid bolus consisting of Ringer's lactate 10 ml kg À1 was administered during 10 min, and a postinfusion measurement was obtained. Vasoactives were then discontinued and MAP was given 20-30 min to return to the baseline value (baseline 2). A controlled stepwise bleeding (10 ml every 5 min until a total blood loss of 15 ml kg
À1
) was performed, and a postbleeding measurement was obtained immediately after the last step. A schematic representation of the experimental protocol is shown in Fig. 1 .
Aortic flow and arterial pressure waveforms were simultaneously recorded for 2 min at the beginning of each protocol stage. After completion of the study, animals were killed with a lethal dose of potassium chloride i.v. checked using the Kolmogorov-Smirnov test, with Lilliefors significance correction. Differences between groups over time were assessed by two-way mixed analysis of variance (ANOVA), with the Greenhouse-Geisser correction when violation of sphericity was detected according to the Mauchly test, using group (phenylephrine or nitroprusside) as the between-subject factor and experimental stage as the within-subject factor. Differences were assessed by Student's independent or paired t-test.
Statistical analysis
Relationships between continuous variables were assessed by linear regression analysis. A linear mixed-effects model analysis was used to determine the contribution of arterial load [covariates: Ea, logarithmic transformation of C (logC), R, and Z c ] and cardiac parameters [covariates: HR, corrected aortic flow time (FTc), mean acceleration of aortic blood flow (Acc), and PV] on Ea dyn and its components, SVV and PPV. Arterial and cardiac models were constructed using individual animals as subjects for random factors, and sequential experimental stages as repeated measurements. A heterogeneous compound symmetry structure was selected based on the corrected Akaike information criteria (AICc) value. 20 21 Model parameters were estimated via the restricted maximum likelihood method, and the estimated fixed effect of each parameter was quantified by use of estimated value and standard error (SE). Comparison of goodness of fit of arterial and cardiac models was performed considering the AICc; the smaller the AICc, the better the model describes the data. 22 A mixed-effect regression analysis was also used to evaluate the relationship between MAP and Ea dyn . A P-value of <0.05 was considered statistically significant. All statistical analyses were two-tailed and performed using MedCalc Statistical Software version 16.5.0 (MedCalc Software bvba, Ostend, Belgium; http://www.medcalc.org; 2015) and SPSS (SPSS 21; SPSS Inc., Chicago, IL, USA).
Results
The mean dosage for nitroprusside was 7 (5) lg kg À1 min
À1
(from 2 to 17 lg kg À1 min
) and for phenylephrine 2 (1) lg kg
). Phenylephrine increased and nitroprusside decreased MAP by 56 and 46%, respectively. Haemodynamic variables during the different experimental stages are detailed in Table 1 .
Effects of pharmacological changes of arterial load
As expected, phenylephrine and nitroprusside infusions resulted in opposite changes in static components of arterial load. Furthermore, whereas static variables of arterial load increased 
Effects of fluid bolus
The effects of fluid administration during different experimental stages are detailed in Table 2 
Effects of blood withdrawal
Considering both experimental groups, haemorrhage decreased SV from 2.9 (0.7) to 2.4 (0.5) ml (P<0.001), but did not affect CO [from 0.36 (0.11) to 0. 34 
Relationship between PPV and SVV during experimental stages
Evolution of Ea dyn , PPV, and SVV in both groups during the experiment is shown in Fig. 2 . Considering all stages, the relationship between PPV and SVV was high (R 2 ¼0.70; P<0.0001;
Supplementary material).

Contributions of arterial load and cardiac parameters to Ea dyn , PPV, and SVV
A mixed-linear model was run to analyse the contribution of arterial load and cardiac related parameters to Ea dyn , PPV, and SVV. This allowed determination of the effects of arterial load and cardiac factors, considering correlation between subjects and non-constant variability over time.
The estimates for arterial load and cardiac parameters are shown in Table 3 . Both PPV and SVV were correlated with Ea, C, R, and HR. However, PPV was also associated with PV and Acc. The overall result is that Ea dyn was related to arterial load (C and R) but also to cardiac variables (HR, PV, and Acc). Furthermore, even if PPV and SVV were affected by similar arterial and cardiac parameters, the magnitude of their effects was significantly different. For example, holding other independent predictors constant, for a relative increase of 10% in C, an absolute increase in PPV of 0.75 units should be expected. In contrast, for the same relative change in C, an increase of 0.47 units in SVV would be observed. Therefore, PPV and SVV were not associated to the same degree with arterial load and cardiac factors, which explains their discrepancies; hence, the behaviour of Ea dyn through different experimental stages.
A mixed-effect regression analysis also showed that a 10 mm Hg increase in MAP was significantly associated with a 0.1 unit decrease in Ea dyn (Fig. 3) .
Discussion
In this experimental study, we aimed to determine the impact of arterial load changes during different haemodynamic conditions on Ea dyn , PPV, and SVV. We demonstrated that changes in arterial load significantly affected Ea dyn . We also found that the impact of arterial and cardiac factors was different for PPV and SVV, which could explain the discrepancies observed between both variables and the evolution of Ea dyn throughout the experiment.
In order to gain a proper understanding of how the arterial pressure is generated, it should be considered that arterial pressure is the final product from the interaction of the arterial load with the flow ejected by the heart. 12 Arterial pressure therefore depends on left ventricular ejection and arterial load. Accordingly, the magnitude of arterial PP should reflect SV as long as the arterial load remains stable. However, as the pressure-flow relationship is not constant and can be affected by variations in arterial load, the relationship between PP and left ventricular SV may change over time. 23 24 Respiratory variations in left SV during MV are the result of the combined actions of IPPV on right and left ventricular preload and afterload. 25 Moreover, the magnitude of these changes defines the preload dependence of cardiac output and depicts the slope of the cardiac function curve. 1 Provided that arterial load conditions are relatively constant during a single respiratory cycle, 26 it can be assumed that changes in PP should mainly reflect the effects of MV on left ventricular SV. 3 For that reason, PPV has been extensively used as a surrogate for SVV. 1 However, although variations in the arterial system during a respiratory cycle are usually considered to be negligible, 27 significant changes in arterial load could alter the relationship between respiratory variations in arterial PP and SV (i.e. Ea dyn ). Although the effects of vasoactive therapy, 6 8 28 bleeding, 5 28 fluid loading, 10 19 or changes in contractility 3 on both PPV and SVV have been previously described, this is the first study, to the best of our knowledge, designed to determine the underlying mechanisms defining the relationship between PPV and SVV, and the factors that determine Ea dyn .
A major finding in our study was that Ea dyn changed in the opposite direction to the arterial load during pharmacological intervention. We observed that when arterial load is increased using phenylephrine, Ea dyn decreased. On the contrary, if arterial load was reduced with nitroprusside, the Ea dyn increased. Although this finding appears paradoxical and seems to conflict with preliminary reports about the nature of Ea dyn , 19 our results are in agreement with basic physiology; owing to the non-linearity of the systemic arterial pressure-flow relationship and the role of baroreceptor reflex control, 29 30 the greater the arterial pressure, the lower the further increase if flow is augmented; hence, the lesser the expected Ea dyn . This finding supports the hypothesis that Ea dyn does not represent any physical property of the arterial load, such as compliance or resistance, but rather a variable describing the dynamic interaction between pressure and flow. Another interesting observation of this study is that Ea dyn was also affected by HR and the velocity and acceleration of aortic blood flow. This is not surprising because, for a given arterial load, the contour of the arterial pressure is also determined by the ventricular ejection pattern. 16 32 Therefore, although arterial load seems to play a prominent role in our study, the impact of cardiac factors could explain, in part, the divergence observed between PPV and SVV. For that reason, we argue that Ea dyn should be more properly considered as a ventriculo-arterial coupling parameter involving both cardiac and arterial factors. Although this assumption seems to be plausible, it needs further confirmation. Our study has important limitations. Firstly, although we chose phenylephrine and nitroprusside because of their selective profiles on the arterial system, we cannot exclude changes in venous return and cardiac contractility. 33 34 However, as the impact of venous return should influence both SVV and PPV in a similar manner, variations in cardiac contractility could alter the pattern of ventricular ejection and, thus, the PPV and SVV relationship. Moreover, the assessment of cardiac related factors was limited only to an estimation of HR and aortic blood flow profile. A more detailed evaluation of the contribution of the heart, as provided by maximal ventricular elastance or by specifically changing inotropic state, could reveal a more prominent role of the heart in the PPV and SVV relationship. Secondly, our arterial load assessment was grounded in a simplified three-element Windkessel model of the circulation. Although this model is generally assumed to be a useful representation of the main features of the arterial system, 14 it is not suitable for explaining its non-uninform and finite nature. 16 35 Arterial load compromises not only the mechanical properties of the arterial system, such as compliance or resistance, but also the effects of arterial wave reflections. 36 An acute change in arterial load, as seen during phenylephrine or nitroprusside infusion or during acute and profound bleeding, could alter arterial reflections by modifying mechanical properties and pulse wave propagation. Given that arterial pressure is the combination of cardiac and arterial factors, the impact of changes in arterial propagation and reflection phenomena was not accounted for by our methodology. Moreover, even if optimal damping of the arterial waveform was carefully checked, the use of fluid-filled catheters could have affected our pressure measurements. Finally, our experimental study was performed on healthy young rabbits submitted to anaesthesia with known cardiovascular effects, so our results should be interpreted with caution when extrapolating to human cardiovascular physiology.
In conclusion, acute modifications of arterial load significantly affected Ea dyn . The relationships between PPV and SVV were explained by the interaction between arterial and cardiac factors. Therefore, Ea dyn should be more properly considered as a ventriculo-arterial coupling index influenced by the interaction of arterial and cardiac factors. 
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